News – Page 6 – Global Reach Health

November 1, 2023

FDA Approves Voquezna (vonoprazan) for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults

November 1, 2023 - Phathom Pharmaceuticals, Inc. a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal

October 31, 2023

FDA Approves Wezlana (ustekinumab-auub), an Interchangeable Biosimilar to Stelara

October 31, 2023 - The U.S. Food and Drug Administration has approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab)

October 26, 2023

FDA Approves Agamree (vamorolone) for the Treatment of Duchenne Muscular Dystrophy

October 26, 2023 - Catalyst Pharmaceuticals, Inc. has reported that Santhera Pharmaceuticals has obtained U.S. Food and Drug Administration ("FDA") approval for Agamree^®

October 26, 2023

FDA Approves Omvoh (mirikizumab-mrkz), a First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis

October 26, 2023 - Eli Lilly and Company has announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh^TM (mirikizumab-mrkz)

October 25, 2023

Exela Issues Voluntary Nationwide Recall of Sodium Bicarbonate 8.4%, Midazolam in 0.8% Sodium Chloride, and ELCYS Injections Due to Presence of Particulate Matter

October 25, 2023 - Exela Pharma Sciences, LLC, (Exela) is voluntarily recalling the products listed in the table below to the consumer level. Particulate matter

October 23, 2023

FDA Approves Zymfentra (infliximab-dyyb) Subcutaneous Formulation for the Treatment of People with Inflammatory Bowel Disease

October 23, 2023 - Celltrion USA has announced that the U.S. Food and Drug Administration (FDA) has approved Zymfentra (infliximab-dyyb) for maintenance therapy

October 22, 2023

Botanical-Be Issues Voluntary Nationwide Recall of Kuka Flex Forte, Artri King, and Reumo Flex (Capsules) Due to Presence of Undeclared Diclofenac

October 22, 2023 - Botanical-Be is voluntarily recalling all lots of Kuka Flex Forte Capsules, Artri King, Capsules, and Reumo Flex Capsules to the consumer level.

October 20, 2023

FDA Approves Penbraya (meningococcal groups A, B, C, W and Y vaccine) for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents

October 20, 2023 - Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Penbraya^TM